Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
TACE-LVD seems to be a feasible, safe, and effective strategy for rapid FLR hypertrophy. Moreover, TACE-LVD may be a therapeutic choice if insufficient FLR hypertrophy precludes resection. This strategy warrants further exploration.
Authors
- Shugeng Zhang (ORCID: https://orcid.org/0000-0001-9832-9784)
- Shenyu Zhang (ORCID: https://orcid.org/0009-0004-2338-4016)
- Ruipeng Song (ORCID: https://orcid.org/0000-0002-1912-3735)
- Jiabei Wang (ORCID: https://orcid.org/0000-0002-4578-3817)
- Lianxin Liu (ORCID: https://orcid.org/0000-0002-3535-6467)
- Jun Xu (ORCID: https://orcid.org/0000-0003-4221-5563)
- Yao Liu (ORCID: https://orcid.org/0000-0003-0365-3229)
- Wei Long Cai (ORCID: https://orcid.org/0000-0002-4474-6686)
- Huan‐Zhang Yao
- Fanzheng Meng (ORCID: https://orcid.org/0000-0003-3985-214X)
- Dalong Yin
- Hangcheng Zhou
- Yipeng Fei
- Shaopeng Li (ORCID: https://orcid.org/0000-0002-1730-3433)
- Changlong Hou
- Jizhou Wang (ORCID: https://orcid.org/0000-0002-6934-072X)
Institutions
- University of Science and Technology of China (CN)
- Anhui Provincial Center for Disease Control and Prevention (CN)
- Anhui Provincial Hospital (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/jhc.s495304
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China